| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 24.787 | 9.957 | 25.464 | 29.092 | 11.721 | 13.855 | 10.846 | 4.575 | 4.879 | 5.148 |
| Total Income - EUR | 25.218 | 12.817 | 26.645 | 30.253 | 12.856 | 14.968 | 11.935 | 5.667 | 5.580 | 5.148 |
| Total Expenses - EUR | 22.212 | 12.757 | 15.251 | 20.543 | 12.399 | 16.846 | 17.339 | 18.589 | 10.752 | 1.843 |
| Gross Profit/Loss - EUR | 3.006 | 61 | 11.393 | 9.710 | 457 | -1.877 | -5.404 | -12.922 | -5.172 | 3.305 |
| Net Profit/Loss - EUR | 2.587 | 50 | 9.570 | 9.419 | 340 | -2.015 | -5.513 | -12.967 | -5.221 | 3.133 |
| Employees | 1 | 1 | 2 | 2 | 2 | 1 | 2 | 2 | 1 | 0 |
Check the financial reports for the company - Biorara Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 10.893 | 10.162 | 8.473 | 17.475 | 12.622 | 7.953 | 3.445 | 826 | 0 | 0 |
| Current Assets | 4.661 | 7.754 | 15.378 | 19.115 | 17.018 | 20.492 | 15.204 | 4.387 | 2.658 | 3.957 |
| Inventories | 526 | 1.128 | 1.262 | 1.655 | 1.623 | 1.592 | 1.557 | 0 | 0 | 0 |
| Receivables | 0 | 2.476 | 4.960 | 15.805 | 14.800 | 13.990 | 8.927 | 2.358 | 2.325 | 2.303 |
| Cash | 4.135 | 4.150 | 7.405 | 1.655 | 595 | 4.909 | 4.720 | 2.029 | 333 | 1.653 |
| Shareholders Funds | 4.245 | 4.251 | 13.750 | 21.928 | 21.843 | 19.414 | 13.471 | 546 | -4.677 | -1.518 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 3.967 | 13.664 | 3.448 | 9.289 | 3.661 | 6.087 | 3.388 | 3.963 | 7.335 | 5.474 |
| Income in Advance | 9.261 | 7.967 | 6.653 | 5.374 | 4.135 | 2.943 | 1.790 | 703 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7022 - 7022" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Biorara Srl